Development of Electrochemical Lactate Biosensor: A Review

Hanif Tri Hartanto, Nurul Intan, Basari Basari, Siti Fauziyah Rahman

Research output: Contribution to journalConference articlepeer-review

Abstract

Due to the lack of early-stage symptoms, diabetes mellitus is known as the "silent killer". The prevalence of diabetes mellitus is significant and will continue to rise annually. Metformin is one of the treatments offered to people with diabetes mellitus. This medicine may lower blood glucose concentrations. In addition to the advantages of metformin, it causes lactic acidosis and can cause metformin-related lactic acidosis (MALA), which is associated with a mortality rate of 30-50%. This study discusses the determination methods of lactic acid levels in saliva samples of type 2 diabetes mellitus using an electrochemical biosensor. A review of a working electrode, enzyme immobilization methods, sample, the limit of detection, linear range, and stability of lactic acid biosensor.

Original languageEnglish
Article number110007
JournalAIP Conference Proceedings
Volume3080
Issue number1
DOIs
Publication statusPublished - 7 Mar 2024
Event15th Asian Congress on Biotechnology in conjunction with the 7th International Symposium on Biomedical Engineering, ACB-ISBE 2022 - Bali, Indonesia
Duration: 2 Oct 20226 Oct 2022

Keywords

  • biosensor
  • diabetes mellitus
  • electrochemical
  • lactate

Fingerprint

Dive into the research topics of 'Development of Electrochemical Lactate Biosensor: A Review'. Together they form a unique fingerprint.

Cite this